ICAM-1 antisense therapy: a new treatment concept on Crohn disease? Placebo controlled study of ICAM-1 antisense oligonucleotide therapy in Crohn disease;ICAM-l-Antisense-Therapie: Ein neues Behandlungskonzept beim M. Crohn? Plazebokontrollierte Studie einer ICAM-l-Antisense-Oligonukleotidtherapie beim M. Crohn.

Zeitschrift für Gastroenterologie

Volumn 37, Issue 4, 1999, Pages 313-315

  Martignoni, M E ^a   Friess, H ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CROHN DISEASE; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; OLIGONUCLEOTIDES, ANTISENSE;

EID: 0033114118     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)